Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis
Other
OA: closed
CC0
⤵ 6 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This randomized controlled trial investigated the efficacy of superovulation and insemination for treating infertility in women with minimal or mild endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (6)
- Ovulation induction with clomiphene citrate or letrozole following laparoscopy in infertile women with minimal to mild endometriosis: a prospective randomised controlled trial 2021
- External validation of the Endometriosis Fertility Index in a French population 2015
- A physiological approach for treating endometriosis by recombinant pigment epithelium-derived factor (PEDF) 2013
- Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility 2012
- Endometriosis and infertility: epidemiology and evidence-based treatments 2008
- Advances in treatment options of endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T22:00:22.376048+00:00
License: CC0
· commercial use OK